1.
Bioorg Med Chem Lett
; 14(12): 3155-9, 2004 Jun 21.
Artículo
en Inglés
| MEDLINE
| ID: mdl-15149665
RESUMEN
A series of (5-(2H)-isoxazolonyl) ureas were developed as nanomolar inhibitors of hormone-sensitive lipase, an enzyme of potential importance in the treatment of diabetes.